CNTN Stock Forecast: Canton Strategic Holdings, Inc. Price Predictions for 2026-2027

Last close, 18 Nov 2026
$1.34

Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 7 of 100 as at 18 Nov 2026 — in the weakest quartile.

Market cap
$108.6M
Ticker Nerd rank
7/ 100
Median analyst target
—
Analysts covering
—
Revenue$1.5M
Operating income−$1.2M
Net income−$19.3M
Free cash flow−$7.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Canton Strategic Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 18 Nov 2026
7/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Quality
46
Momentum
38
Volatility
27
Issuance
20
Revisions
20
Growth
15
Value
5
Accruals
5

Quality (46): The business earns solid, repeatable profits on what it owns.

Accruals (5): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

CNTN stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CNTN, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

CNTN appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Estimates

CNTN analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
24.4×

Cheaper than 7% of US stocks

Price / book
0.3×

Cheaper than 93% of US stocks

EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
—
Operating margin
—
Net margin
—
Returns & dividend
Return on equity
−62.2%

Higher than 19% of US stocks

Return on assets
−12.2%

Higher than 25% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Canton Strategic Holdings, Inc. has a market value of $108.6M and an enterprise value of $89.0M.

  • Revenue in the twelve months to 30 June 2026: $1.5M.

  • Net income over the same four quarters: −$98.1M, a −6559.3% net margin.

  • Free cash flow in the twelve months to 30 June 2026: −$159.3M.

  • Shares outstanding: 77.3M.

  • Canton Strategic Holdings, Inc. employs 12 people — $125K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 18 Nov 2026

Data provided by Twelve Data

Peers

CNTN and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelBiotechnology
CompanyMarket capTKN rank
CNTNCanton Strategic Holdings, Inc.$108.6M7
NERVMinerva Neurosciences, Inc.$108.6M28
CMPXCompass Therapeutics, Inc.$110.0M29
GNLXGenelux Corp.$107.7M14
FHTXFoghorn Therapeutics, Inc.$104.9M56
CBUSCibus, Inc.$104.4M27
OKUROnKure Therapeutics, Inc.$113.9M52

Take a look at CNTN’s peer groups, ranked by the model: financial stocks · biotech stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Canton Strategic Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about CNTN

How does Ticker Nerd's model rank CNTN?

As at 18 Nov 2026, Canton Strategic Holdings, Inc. ranks 7 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Quality (46 of 100).

What is the CNTN stock forecast for 2030?

No analyst covering Canton Strategic Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CNTN are extrapolating price history, which says nothing about the business.

What does Canton Strategic Holdings, Inc. do?

Canton Strategic Holdings, Inc. is a U.S.-based public company focused on two distinct operating areas: digital asset treasury activities tied to the Canton Network and clinical-stage biotechnology research and development. The company works to support institutional blockchain adoption through the use of Canton Coin, network validation, and ecosystem participation, helping enable the digitization of financial market infrastructure.

Company

About Canton Strategic Holdings, Inc.

Canton Strategic Holdings, Inc. is a U.S.-based public company focused on two distinct operating areas: digital asset treasury activities tied to the Canton Network and clinical-stage biotechnology research and development. The company works to support institutional blockchain adoption through the use of Canton Coin, network validation, and ecosystem participation, helping enable the digitization of financial market infrastructure. Alongside its blockchain-related activities, Canton Strategic Holdings maintains a biotechnology segment centered on developing therapeutic candidates for inflammation, immunology, and other specialized medical conditions. Its business model combines participation in emerging digital asset infrastructure with life sciences research, giving it a position at the intersection of financial technology and biotechnology. Canton Strategic Holdings, Inc. is headquartered in Red Bank, New Jersey.

CEO Mr. Mark Wendland · 12 employees · United States · https://www.cantonstrategic.com